论文部分内容阅读
[目的]探讨思连康在幽门螺杆菌(HP)阳性患儿根治治疗中的辅助作用。[方法]将确诊为HP感染并且需要治疗的5～14岁的120例患儿分为A组和B组,各组60例,A组按标准三联疗法根治HP,B组在A组的治疗基础上加用思连康。[结果]A组根治HP成功率为80.0%(48/60),B组成功率为93.3%(56/60);2组比较,差异有统计学意义(P<0.05)。[结论]思连康对根治儿童HP有协同作用。
[Objective] To explore the auxiliary effect of Si Lian Kang in radical treatment of Helicobacter pylori (HP) -positive children. [Methods] 120 cases aged 5-14 years diagnosed with HP infection and needing treatment were divided into group A and group B, 60 cases in each group, group A was treated with standard triple therapy and group B was treated with group A Based on the use of Si Lian Kang. [Results] The success rate of radical cure of HP in group A was 80.0% (48/60), and that of group B was 93.3% (56/60). There was significant difference between two groups (P <0.05). [Conclusion] Si Lian Kang has a synergistic effect on the radical treatment of children with HP.